In plain words
A triptan is a type of medicine that narrows blood vessels in the head and eases a attack once it has started. Sumatriptan is the most common example. Triptans are not used to prevent migraines. In pregnancy the question is whether the benefit to the mother outweighs any risk to the baby. Studies so far come mostly from large registries and cohorts rather than trials, and they have not found a clear rise in major birth defects. Some providers prescribe a triptan for severe attacks. The question for a provider is which option fits a person's history.
The deeper version
Triptans are serotonin 5-HT1B/1D agonists with vasoconstrictive activity. Acute-treatment data in pregnancy are observational. Cohort analyses, including the Norwegian Mother, Father and Child Cohort Study and registry data gathered by the Organization of Teratology Information Specialists, report no clear increase in major malformations overall, with sample sizes limiting the detection of rare outcomes. Professional societies generally treat sumatriptan as a reasonable option for acute treatment when needed, and advise against ergot derivatives in pregnancy. The main controversy is whether observational reassurance applies to all triptans and to repeated exposure, since most data concern sumatriptan.
Where it comes up
- Headaches and migrainesPregnancy: Your Body
- Headaches after birthPostpartum: Your Body
- Medications and breastfeeding: how to checkFeeding Your Baby
- High blood pressure and preeclampsiaPregnancy: Your Body
What mothers here say about triptan
No one has posted under this term yet.
Sources
- American Headache Society — Position Statement on Migraine Therapy in Pregnancy and Lactation, 2021
- Norwegian Institute of Public Health — Norwegian Mother, Father and Child Cohort Study (MoBa): analyses of triptan exposure in pregnancy
- Organization of Teratology Information Specialists — OTIS Fact Sheet: Migraine Medications in Pregnancy